Immune Cells

Genome Editing

Genome Editing of Immune Cells

CRISPR-Cas9 genome editing of immune cell types holds great therapeutic potential, but application of genome editing to primary human immune cells has been hampered by challenges in efficient delivery and expression of the CRISPR machinery. Explore our protocols and resources for information on how to overcome these barriers and perform high-efficiency genome editing of these difficult-to-manipulate cell types in your own lab.

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.